My humble answer: I would image the patent for xopenex (levalbuterol) should be running out soon. I know for a fact one of the makers of albuterol are ready to launch their own generic of levalbuterol. I'm sure this will happen as soon as the xopenex patent runs out. The price should start dropping once generics are on the market. I don't know that levalbuterol is really any better than albuterol, yet I do see the day when levalbuterol replaces albuterol as the most popular asthma medicine. Once the price of levalbuterol is comparable to albuterol, insurance companies will have no choice but to start paying for it, you'd think.
0 comments:
Post a Comment